| A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia T Borsello, PGH Clarke, L Hirt, A Vercelli, M Repici, DF Schorderet, ... Nature medicine 9 (9), 1180-1186, 2003 | 837 | 2003 |
| Recent techniques for tracing pathways in the central nervous system of developing and adult mammals A Vercelli, M Repici, D Garbossa, A Grimaldi Brain research bulletin 51 (1), 11-28, 2000 | 331 | 2000 |
| DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson’s disease L Zondler, L Miller-Fleming, M Repici, S Gonçalves, S Tenreiro, ... Cell death & disease 5 (7), e1350-e1350, 2014 | 182 | 2014 |
| DJ-1 in Parkinson’s disease: clinical insights and therapeutic perspectives M Repici, F Giorgini Journal of clinical medicine 8 (9), 1377, 2019 | 179 | 2019 |
| Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons C Centeno, M Repici, JY Chatton, BM Riederer, C Bonny, P Nicod, ... Cell Death & Differentiation 14 (2), 240-253, 2007 | 154 | 2007 |
| Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation M Repici, C Centeno, S Tomasi, G Forloni, C Bonny, A Vercelli, T Borsello Neuroscience 150 (1), 40-49, 2007 | 99 | 2007 |
| Age-dependent impairment of spine morphology and synaptic plasticity in hippocampal CA1 neurons of a presenilin 1 transgenic mouse model of Alzheimer's disease A Auffret, V Gautheron, M Repici, R Kraftsik, HTJ Mount, J Mariani, ... Journal of Neuroscience 29 (32), 10144-10152, 2009 | 79 | 2009 |
| Cyclooxygenase-2 and caspase 3 expression in trimethyltin-induced apoptosis in the mouse hippocampus MC Geloso, A Vercelli, V Corvino, M Repici, M Boca, K Haglid, G Zelano, ... Experimental Neurology 175 (1), 152-160, 2002 | 74 | 2002 |
| NOS inhibition during postnatal development leads to increased ipsilateral retinocollicular and retinogeniculate projections in rats A Vercelli, D Garbossa, S Biasiol, M Repici, S Jhaveri European Journal of Neuroscience 12 (2), 473-490, 2000 | 69 | 2000 |
| Adaptive and behavioral changes in kynurenine 3-monooxygenase knockout mice: relevance to psychotic disorders S Erhardt, A Pocivavsek, M Repici, XC Liu, S Imbeault, DC Maddison, ... Biological psychiatry 82 (10), 756-765, 2017 | 66 | 2017 |
| Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease A Vittori, C Breda, M Repici, M Orth, RAC Roos, TF Outeiro, F Giorgini, ... Human molecular genetics 23 (12), 3129-3137, 2014 | 62 | 2014 |
| The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability A Colombo, M Repici, M Pesaresi, S Santambrogio, G Forloni, T Borsello Cell Death & Differentiation 14 (10), 1845-1848, 2007 | 55 | 2007 |
| c-Jun N-terminal kinase binding domain–dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross … M Repici, L Mare, A Colombo, C Ploia, A Sclip, C Bonny, P Nicod, ... Neuroscience 159 (1), 94-103, 2009 | 54 | 2009 |
| JNK pathway as therapeutic target to prevent degeneration in the central nervous system M Repici, T Borsello Hypoxia and Exercise, 145-155, 2007 | 50 | 2007 |
| Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury M Repici, X Chen, MP Morel, M Doulazmi, A Sclip, V Cannaya, ... Neurobiology of Disease 46 (3), 710-721, 2012 | 48 | 2012 |
| The Parkinson’s disease-linked protein DJ-1 associates with cytoplasmic mRNP granules during stress and neurodegeneration M Repici, M Hassanjani, DC Maddison, P Garção, S Cimini, B Patel, ... Molecular neurobiology 56, 61-77, 2019 | 47 | 2019 |
| Parkinson’s disease-associated mutations in DJ-1 modulate its dimerization in living cells M Repici, KR Straatman, N Balduccio, FJ Enguita, TF Outeiro, F Giorgini Journal of molecular medicine 91, 599-611, 2013 | 43 | 2013 |
| Macrophage stimulating protein is a novel neurotrophic factor MC Stella, A Vercelli, M Repici, A Follenzi, PM Comoglio Molecular Biology of the Cell 12 (5), 1341-1352, 2001 | 36 | 2001 |
| Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse P Bigini, M Repici, G Cantarella, E Fumagalli, S Barbera, A Cagnotto, ... Neurobiology of disease 29 (3), 465-476, 2008 | 32 | 2008 |
| Neuronal death and neuroprotection: a review M Repici, J Mariani, T Borsello Neuroprotection Methods and Protocols, 1-14, 2007 | 30 | 2007 |
